Momentus Inc. Class A Common Stock

Go to Momentus Inc. Class A Common Stock Website

$0.00

(%)
Live
Previous Close

$

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$7.4 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Momentus Inc offers in-space infrastructure services by building transfer and service vehicles that carry satellites and hosted payloads between orbits in space. It is a provider of three critical functions in the new space economy: Space Transportat...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

U.S. stocks traded slightly lower this morning, ahead of interest-rate decision from the Federal Reserve. Following the market opening Wednesday, the Dow traded down 0.01% to 39,106.88 while the NASDAQ fell 0.06% to 16,157.27. The S&P 500 also fell, dropping, 0.02% to 5,177.26. Check This Out: Exxon Mobil, Palantir Technologies And 2 Other Stocks Insiders Are Selling   Leading and Lagging Sectors   Utilities shares rose by 0.5% on Wednesday. In trading on Wednesday, energy shares fell by 0.5%.   Top Headline   General Mills, Inc. (NYSE: GIS) reported better-than-expected fourth-quarter financial results. General Mills reported a third-quarter FY24 sales decline of 1% year-on-year to $5.099 billion, beating the analyst consensus estimate of $4.962 billion. Adjusted EPS of $1.17 beat the analyst consensus estimate of $1.05.   Equities Trading UP   ETAO International Co., Ltd. (NASDAQ: ETAO) shares shot up 106% to $0.2950. The company announced a reverse stock split. Shares of XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) got a boost, surging 78% to ...

Related tickers: GIS, XTLB, MNTS, SMR, LFCR, ETAO, TRUG.

Read Full Article

Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results. The company reported fiscal year 2023 losses of 96 cents per share, compared to losses of $3.78 per share from the prior year. Taysha reported it had $143.9 million in cash and cash equivalents on Dec. 31, 2023. The company also provided clinical updates including the completed dosing in cohort one of its REVEAL Phase 1/2 adolescent and adult trial and the expansion of the ongoing trial in Canada into the U.S. and initiated site activation. Taysha Gene Therapies shares jumped 27.1% to $2.86 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers ETAO International Co., Ltd. (NASDAQ: ETAO) shares rose 200.4% to $0.4296 in pre-market trading. The company announced a reverse stock split. Oblong, Inc. (NASDAQ: OBLG) rose 48.2% to $0.20 in pre-market trading after the company reported financial results for fourth quarter 2023 and issued a business update. BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) climbed 44% to $0.0288 in pre-market trading after falling 15% on Tuesday. ...

Related tickers: SMR, BCAN, CGC, MGRX, WORX, ETAO, CMND, FUFU, AQST, CERO, HROW, VERB, OBLG, OTRK, TSHA, MNTS, MXCT, EZFL, SOPA, GETY.

Read Full Article
Trending Tickers
CYTO

XNAS

$1.44
(%)
LASE

XNAS

$2.62
(%)
MGAM

XNAS

$0.02
(%)
SXTC

XNAS

$1.04
(%)
MLGO

XNAS

$0.00
(%)